Comparative efficacy and safety of tofacitinib, baricitinib, upadacitinib, filgotinib and peficitinib as monotherapy for active rheumatoid arthritis

Young Ho Lee

Comparative efficacy and safety of tofacitinib, baricitinib, upadacitinib, filgotinib and peficitinib as monotherapy for active rheumatoid arthritis - 2020 - 674-681

Serial 32495356 8006872 45 4 https://doi.org/10.1111/jcpt.13142 Document_8006872_13384.pdf

02694727
London Health Libraries Koha Consortium privacy notice